Loading clinical trials...
Loading clinical trials...
Reduced Intensity Myeloablative Total Body Irradiation and Thymoglobulin Followed by Allogeneic Peripheral Blood Stem Cell Transplantation
Conditions
Interventions
Thymoglobulin
Total-Body Irradiation
+3 more
Locations
1
United States
Virginia Commonwealth University/Massey Cancer Center
Richmond, Virginia, United States
Start Date
July 21, 2008
Primary Completion Date
February 15, 2014
Completion Date
June 28, 2017
Last Updated
November 9, 2018
NCT06152575
NCT06179888
NCT00106925
NCT06285890
NCT06311227
NCT07388563
Lead Sponsor
Virginia Commonwealth University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions